<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20040825155313+02'00'</creation_date><modification_date>D:20040825155313+02'00'</modification_date><initial_authorization>False</initial_authorization><pdf_file>EU-1-00-131_h_dec_15.pdf</pdf_file></head><body><section><header>en  
   en</header></section><section><header>en</header><p>commission of the european communities</p><p>brussels, 23/viii/2004 c(2004) 3333 
 not for publication</p></section><section><header>commission decision of 23/viii/2004 
 amending the marketing authorisation for &quot;pegintron - peginterferon alfa-2b&quot;, a 
 medicinal product for human use, granted by decision c(2000)1407 
 (text with eea relevance)</header><p>only the french and dutch texts are authentic</p></section><section><header>en  
   en</header></section><section><header>commission decision of 23/viii/2004 
 amending the marketing authorisation for &quot;pegintron - peginterferon alfa-2b&quot;, a 
 medicinal product for human use, granted by decision c(2000)1407 
 (text with eea relevance)</header><p>the commission of the european communities, having regard to the treaty establishing the european community,</p><p>
 having regard to council regulation (eec) no 2309/93 of 22 july 1993 laying down 
 community procedures for the authorization and supervision of medicinal products for 
 human and veterinary use and establishing a european agency for the evaluation of 
 medicinal products
 1, having regard to commission regulation (ec) no 1085/2003 of 3 june 2003 concerning 
 the examination of variations to the terms of a marketing authorisation for medicinal 
 products for human use and veterinary medicinal products falling within the scope of 
 council regulation (eec) no 2309/93
 2, and in particular article 6(10) thereof, having regard to the application submitted by schering plough europe on 26 december 
 2003 under article 6(1) of commission regulation (ec) no 1085/2003, 
 having regard to the opinion of the european medicines agency, formulated by 
 committee for medicinal products for human use on 23 june 2004, 
 whereas: 
 (1)</p><p>an examination of the major variation type ii to the terms of the marketing 
 authorisation for the medicinal product &quot;pegintron - peginterferon alfa-2b&quot;, 
 entered in the community register of medicinal products under nos 
 eu/1/00/131/001-050 and authorised by commission decision c(2000)1407 of 
 25 may 2000, has shown that the product still complies with the requirements set 
 out in directive 2001/83/ec of the european parliament and of the council of 6 
 november 2001 on the community code relating to medicinal products for 
 human use
 3.</p><p>
 1 oj l 214, 24.8.1993, p. 1. regulation as amended by commission regulation (ec) no 649/98 (oj l 88, 24.3.1998, p. 7). 
 2 oj l 159, 27.6.2003, p. 24. 3 oj l 311, 28.11.2001, p. 67. directive as last amended by directive 2003/63/ec (oj l 159, 27.6.2003, p. 46).</p></section><section><header>en  
   en</header><p>(2) the application under article 6(1) of regulation (ec) no 1085/2003 to modify 
 the marketing authorisation and to amend decision c(2000)1407 accordingly 
 should therefore be accepted. 
 (3)</p><p>for the sake of clarity and transparency, it is advisable, following the amendment 
 of part or parts of the annexes to a marketing authorisation, to provide for 
 consolidated versions thereof. for this reason, a full set of annexes concerning the 
 marketing authorisation for the medicinal product &quot;pegintron - peginterferon alfa-
 2b&quot; is attached to this decision. 
 has adopted this decision: 
 article 1 decision c(2000)1407 is amended as follows: 1. annex i is replaced by the text set out in annex i to this decision; 
 2. annex iii (a and b) is replaced by the text set out in annex iii to this decision. 
 article 2 this decision is addressed to schering plough europe, rue de stalle, 73, 1180 bruxelles, belgique – stallestraat, 73 – 1180 brussel, belgië. 
 done at brussels, 23/viii/2004 
 for the commission olli rehn 
 member of the commission</p></section></body></xml>